Additional file 2 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer

  • Kuo-Chang Wen (Contributor)
  • Pi Lin Sung (Contributor)
  • TH Alexander Wu (Contributor)
  • Ping Chieh Chou (Contributor)
  • Jun-Hung Lin (Contributor)
  • Chi Ying F Huang (Contributor)
  • Sai Ching J. Yeung (Contributor)
  • Mong Hong Lee (Contributor)

資料集

Description

Additional file 2: Figure S2. The effect of different concentrations of metformin in ovarian cancer cells. Tumor proliferation (2D-colony formation) of mouse ovarian cancer cells treated with different concentrations of metformin. Maximum plasma concentrations (Cmax) of Metformin was clinically around 1.03–4.12 mg/L ( https://www.accessdata.fda.gov/drugsatfda_docs/label/label/2008/020357s031 ,021202s016lbl.pdf).
可用日期一月 1 2020
發行者Unknown Publisher

引用此